Patterns and mechanisms of resistance to β-lactams and β-lactamase inhibitors in uropathogenic Escherichia coli isolated from dogs in Portugal

被引:95
作者
Féria, C
Ferreira, E
Correia, JD
Gonçalves, J
Caniça, M
机构
[1] Univ Tecn Lisboa, Fac Vet Med, CIISA, P-1300477 Lisbon, Portugal
[2] Natl Inst Hlth Dr Ricardo Jorge, Antibiot Resistance Unit, P-1649016 Lisbon, Portugal
关键词
D O I
10.1093/jac/49.1.77
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Little is known about beta-lactam and beta-lactamase inhibitor susceptibilities of uropathogenic Escherichia coli isolates from animals. Seventy-two isolates collected from canine urinary tract infections were studied by disc diffusion and microdilution methods. The mechanisms responsible for amoxicillin resistance were associated with the production of beta-lactamases in 26 (36%) isolates. These beta-lactamases were further characterized by isoelectric focusing (IEF) and PCR, and bla(TEM), bla(OXA-1), bla(SHV) and ampC genes were detected. The isolates were highly resistant to amoxicillin and ticarcillin, with MIC(90)s of 2048 mg/L. The MIC90 of cefalothin was 128 mg/L, but the MIC(90)s of ceftazidime, ceftriaxone, cefotaxime and aztreonam were lower (0.5, 0.06, 0.25 and 0.5 mg/L, respectively). Fourteen isolates were not inhibited by clavulanate. The mechanisms of resistance to beta-lactams and beta-lactamase inhibitors involved the presence of TEM-1 beta-lactamase in 20 isolates, which had an isoelectric point (pI) of 5.4 and were positive for the presence of the bla(TEM) gene. Fourteen of these isolates produced TEM-1 beta-lactamase alone, and the other six showed an additional band at pI 9.0-9.2 on IEF and the ampC gene by PCR, indicating the simultaneous production of AmpC enzyme. IEF showed that one isolate produced AmpC alone and PCR detected the presence of the ampC gene. Three of the 26 beta-lactamases with a pI of 7.6 belonged to the SHV family, which was confirmed by the presence of the bla(SHV) gene. The remaining two beta-lactamases were OXA-1 focusing at 7.4, and were encoded by the bla(OXA-1) gene. Resistance to beta-lactamase inhibitors was mediated mainly by TEM-1 alone (six of 26) or together with AmpC (four of 26), AmpC alone (one of 26), SHV (one of 26) and OXA-1 (two of 26) enzymes. Clear resistance to extended-spectrum cephalosporins, ceftazidime and ceftriaxone (64 mg/L), was found in one isolate. Isolates producing either AmpC or OXA-1 enzymes or producing high levels of TEM-1 beta-lactamases had susceptibility patterns that were difficult to distinguish without IEF and/or amplification of the corresponding specific genes. This work supports the need for antimicrobial resistance surveillance in veterinary medicine.
引用
收藏
页码:77 / 85
页数:9
相关论文
共 39 条
[1]  
*AM SOC MICR, 1992, CLIN MICR PROC HDB
[2]  
BELAAOUAJ A, 1994, FEMS MICROBIOL LETT, V120, P75
[3]   Characterization of expanded-spectrum cephalosporin resistance in E-coli isolates associated with bovine calf diarrhoeal disease [J].
Bradford, PA ;
Petersen, PJ ;
Fingerman, IM ;
White, DG .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1999, 44 (05) :607-610
[4]   A FUNCTIONAL CLASSIFICATION SCHEME FOR BETA-LACTAMASES AND ITS CORRELATION WITH MOLECULAR-STRUCTURE [J].
BUSH, K ;
JACOBY, GA ;
MEDEIROS, AA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (06) :1211-1233
[5]  
CANICA M, 2000, ARQ MED, V14, P71
[6]   Molecular diversity and evolution of bla(TEM) genes encoding beta-lactamases resistant to clavulanic acid in clinical E-coli [J].
Canica, MMM ;
Lu, CY ;
Krishnamoorthy, R ;
Paul, GC .
JOURNAL OF MOLECULAR EVOLUTION, 1997, 44 (01) :57-65
[7]   PATTERNS AND MECHANISMS OF BETA-LACTAM RESISTANCE AMONG ISOLATES OF ESCHERICHIA-COLI FROM HOSPITALS IN THE UNITED-STATES [J].
COOKSEY, R ;
SWENSON, J ;
CLARK, N ;
GAY, E ;
THORNSBERRY, C .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (05) :739-745
[8]   Occurrence and detection of AmpC beta-lactamases among Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis isolates at a Veterans Medical Center [J].
Coudron, PE ;
Moland, ES ;
Thomson, KS .
JOURNAL OF CLINICAL MICROBIOLOGY, 2000, 38 (05) :1791-1796
[9]  
Courvalin P, 1985, ANTIBIOGRAMME
[10]  
Féria CP, 2000, ADV EXP MED BIOL, V485, P301